Secondly, the phosphor-regulation mechanism of CAP1, as well as the responsible phosphor-regulatory cell signals that are identified, may help to develop strategies for targeting CAP1 in breast cancer therapeutics without directly targeting the cytoskeletal protein. Here, CAP1 is linked to breast carcinoma.